Ranee Mehra, MD, discusses the link between PD-L1 expression and increased immunotherapy efficacy in head and neck squamous cell carcinoma, and what future treatment options may look like for patients in this space.
Advanced practice providers are the future of survivorship care because of the tremendous value they offer to the practice and its patients.
Martin Dietrich, MD, PhD, and Edgardo Santos, MD, FACP, offer closing remarks on unmet needs and future directions in the management of CIM including other disease states where trilaciclib may offer myeloprotective benefit.
Nivolumab/Cabozantinib continued to outperform sunitinib in an updated analysis of the phase 3 CheckMate 9ER trial.
Aaron T. Gerds, MD, MS, unpacks data seen with momelotinib for patients with anemic myelofibrosis.
Discrepancies exist between actual patterns of care and recommendations based on clinical trials in adult patients with mantle cell lymphoma.
For patients receiving an aromatase inhibitor for hormone receptor–positive, HER2-negative breast cancer, the addition of abemaciclib doubled median progression-free survival vs placebo.
Adding the immunotherapy to chemotherapy in the frontline setting may improve overall survival for patients with advanced biliary tract cancer.
Seth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.
Buying one for your practice or enhancing the one you have will help you cut costs and boost your financial stability.
Kristin M. Daly, MSN, ANP-BC, AOCNP, highlights the difference between somatic and germline variants.
The state-of-the-art facility represents the organization’s vision of global cancer care
The last thing patients want is to be put on hold or interrupted by calls at work.
The rise of social media platforms has helped foster a community for adolescent and young adult patients with cancer.
Kara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.
Capivasertib plus fulvestrant improved progression-free survival in patients who have hormone-receptor–positive/HER2-negative advanced breast cancer.
Longer duration of CDK4/6 inhibitor prior to treatment with elacestrant correlated with progression-free survival (PFS) improvements in patients with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer vs standard-of-care options.
Tebentafusp, the first FDA-approved treatment option for patients with unresectable or metastatic uveal melanoma, may cause mild cytokine release syndrome, an expert explains.
Eric Zack, DNP, RN, ACNP-BC, AOCN, BMTCN, describes disseminated intravascular coagulation and best nursing strategies to mitigate the severity of this condition.
A program evaluated at Michigan State University has shown that meditation helps combat burnout and promote well-being among health care workers, particularly in hospice settings.
Undocumented patients with cancer face additional barriers to care.
La-Urshalar Brock, MSN, FNP-BC, CNM, discusses HER2 status and its implications for patients with breast cancer.
“This is a holistic, functional and integrative approach to your mental well-being. So, you start small, and you build up on that. It is not an overnight fix; it is a slow and steady progress.”
Nursing education should be viewed as a long-course endeavor rather than a sprint.
Alyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.
Understanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.
Kellie Zeichner BSN, RN, OCN, explains how her institution created a standardized monitoring procedure for insulinoma care.
Although the CDC has put forth a strong effort to improve its opioid guidelines, many providers still feel that more can be done.
Laurel Sopher was diagnosed with breast cancer while pregnant at 15 weeks. Laurel's son, Alexander, was born in 2000. Laurel also delivered twin boys in 2004.
Chemotherapy education is a puzzle personalized for each patient. Each piece of the puzzle represents a different method of instruction to supplement nurses’ interpersonal teaching.